All News Top News May 18, 2018 CORRECTING and REPLACING Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association Learn More Share Top News May 15, 2018 Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association Learn More Share Top News May 3, 2018 Teva Reports First Quarter 2018 Financial Results Learn More Share Top News May 2, 2018 Teva to Present AUSTEDO® (deutetrabenazine) Tablets Data at the American Psychiatric Association 2018 Annual Meeting Learn More Share Top News Apr 27, 2018 Teva Presents New Long-Term Data Demonstrating Efficacy and Safety of COPAXONE® (glatiramer acetate injection) 40 mg/mL Learn More Share
Top News May 18, 2018 CORRECTING and REPLACING Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association Learn More
Top News May 15, 2018 Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the Journal of the American Medical Association Learn More
Top News May 2, 2018 Teva to Present AUSTEDO® (deutetrabenazine) Tablets Data at the American Psychiatric Association 2018 Annual Meeting Learn More
Top News Apr 27, 2018 Teva Presents New Long-Term Data Demonstrating Efficacy and Safety of COPAXONE® (glatiramer acetate injection) 40 mg/mL Learn More
Earth Day and Every Day Our commitment to acting sustainably and treating the environment with respect Learn More